Results
1 -
10 of
20
(Click
here to explore results)
- Natural Product Chemistry for Drug Discovery, Chapter 11 A Snapshot of Natural Product-Derived Compounds in Late Stage Clinical Development at the End of 2008. Mark S. Butler
, 2009
, Pages 321-354
- Cytotoxic Payloads for Antibody–Drug Conjugates, CHAPTER 6 Colchicine-, Vinblastine-, Taxol- and Eribulin-based Payloads for Antibody–Drug Conjugates (ADCs). Arpita Velani, Syafiq Kay, Earl F. Albone, David E. Thurston
, 2019
, Pages 117-136
- Chemical Linkers in Antibody-Drug Conjugates (ADCs), Chapter 9 The Use of Uniform PEG Compounds in the Design of ADCs. M. W. Giese, R. H. Woodman, G. T. Hermanson, P. D. Davis
, 2022
, Pages 286-376
- Macrocycles in Drug Discovery, CHAPTER 1 Bioactive Macrocycles from Nature. David J. Newman, Gordon M. Cragg
, 2015
, Pages 1-36
- The Discovery and Utility of Chemical Probes in Target Discovery, CHAPTER 6 Discovery and Use of Natural Products and Derivatives as Chemical Probes. Masaki Kita, Hideo Kigoshi
, 2021
, Pages 124-149
- Sustainable Synthesis of Pharmaceuticals: Using Transition Metal Complexes as Catalysts, Chapter 8 C–C Bond Formation in the Sustainable Synthesis of Pharmaceuticals. L. M. D. R. S. Martins, A. M. F. Phillips, A. J. L. Pombeiro
, 2018
, Pages 193-229
- Chemical Linkers in Antibody-Drug Conjugates (ADCs), Chapter 3 Linker Design and Impact on ADC Properties. M. Frigerio, N. Camper
, 2022
, Pages 71-135
- DNA Damage, DNA Repair and Disease: Volume 2, Chapter 26 Evolving DNA Repair Targets for Cancer Therapy. M. T. Sadiq, S. Madhusudan
, 2021
, Volume 2
, Pages 254-285
- Cytotoxic Payloads for Antibody–Drug Conjugates, Contents
, 2019
, Pages P011-P021
- Macrocycles in Drug Discovery, Subject Index
, 2015
, Pages 487-499